USANA Health Sciences Inc (USNA) stock
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Oct 3, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.24+0.51 (+4.01%)
Close on Nov 13, 2026Market cap $244.63MP/E –Yield –
USANA Health Sciences ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
USANA Health Sciences's ebitda for the twelve months ending Oct 3, 2026 was $28.88M, down 58.6% year over year. For fiscal 2025 it was $69.99M, down 13.4% from the year before. Over ten years it grew -7.4% a year on average. The highest annual figure on record is $205.20M in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $69.99M | -13.4% |
| FY2024 | Dec 28, 2024 | $80.86M | -23.6% |
| FY2023 | Dec 30, 2023 | $105.77M | -12.6% |
| FY2022 | Dec 31, 2022 | $121.01M | -34.0% |
| FY2021 | Jan 1, 2022 | $183.23M | -3.7% |
| FY2020 | Jan 2, 2021 | $190.24M | +18.2% |
| FY2019 | Dec 28, 2019 | $160.93M | -21.6% |
| FY2018 | Dec 29, 2018 | $205.20M | +38.1% |
| FY2017 | Dec 30, 2017 | $148.61M | -2.3% |
| FY2016 | Dec 31, 2016 | $152.10M | +0.3% |
| FY2015 | Jan 2, 2016 | $151.64M | +21.4% |
| FY2014 | Jan 3, 2015 | $124.91M | -0.7% |
| FY2013 | Dec 28, 2013 | $125.76M | +17.5% |
| FY2012 | Dec 29, 2012 | $107.01M | +24.8% |
| FY2011 | Dec 31, 2011 | $85.73M | +12.6% |
| FY2010 | Jan 1, 2011 | $76.13M | +31.6% |
| FY2009 | Jan 2, 2010 | $57.86M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Oct 3, 2026 | $6.67M | -27.1% |
| Q2 FY2026 | Jul 4, 2026 | -$12.32M | -150.4% |
| Q1 FY2026 | Apr 4, 2026 | $22.15M | -7.7% |
| Q4 FY2025 | Jan 3, 2026 | $12.38M | +1.4% |
| Q3 FY2025 | Sep 27, 2025 | $9.14M | -52.3% |
| Q2 FY2025 | Jun 28, 2025 | $24.46M | +13.0% |
| Q1 FY2025 | Mar 29, 2025 | $24.01M | -13.7% |
| Q4 FY2024 | Dec 28, 2024 | $12.21M | -55.0% |
| Q3 FY2024 | Sep 28, 2024 | $19.17M | -8.2% |
| Q2 FY2024 | Jun 29, 2024 | $21.65M | -21.6% |
| Q1 FY2024 | Mar 30, 2024 | $27.83M | -7.7% |
| Q4 FY2023 | Dec 30, 2023 | $27.13M | +5.0% |
| Q3 FY2023 | Sep 30, 2023 | $20.88M | -20.0% |
| Q2 FY2023 | Jul 1, 2023 | $27.62M | -15.6% |
| Q1 FY2023 | Apr 1, 2023 | $30.14M | -17.1% |
| Q4 FY2022 | Dec 31, 2022 | $25.84M | -25.7% |
| Q3 FY2022 | Oct 1, 2022 | $26.10M | -40.7% |
| Q2 FY2022 | Jul 2, 2022 | $32.72M | -42.6% |
| Q1 FY2022 | Apr 2, 2022 | $36.35M | -23.4% |
| Q4 FY2021 | Jan 1, 2022 | $34.79M | -37.6% |
| Q3 FY2021 | Oct 2, 2021 | $44.01M | -9.9% |
| Q2 FY2021 | Jul 3, 2021 | $57.00M | +32.1% |
| Q1 FY2021 | Apr 3, 2021 | $47.43M | +11.6% |
| Q4 FY2020 | Jan 2, 2021 | $55.77M | +15.9% |
| Q3 FY2020 | Sep 26, 2020 | $48.82M | +25.2% |
| Q2 FY2020 | Jun 27, 2020 | $43.14M | +23.4% |
| Q1 FY2020 | Mar 28, 2020 | $42.51M | +9.4% |
| Q4 FY2019 | Dec 28, 2019 | $48.13M | -8.6% |
| Q3 FY2019 | Sep 28, 2019 | $38.99M | -21.3% |
| Q2 FY2019 | Jun 29, 2019 | $34.95M | -36.8% |
| Q1 FY2019 | Mar 30, 2019 | $38.87M | -18.4% |
| Q4 FY2018 | Dec 29, 2018 | $52.68M | +31.0% |
| Q3 FY2018 | Sep 29, 2018 | $49.56M | +39.7% |
| Q2 FY2018 | Jun 30, 2018 | $55.30M | +51.2% |
| Q1 FY2018 | Mar 31, 2018 | $47.66M | +31.1% |
| Q4 FY2017 | Dec 30, 2017 | $40.21M | +13.6% |
| Q3 FY2017 | Sep 30, 2017 | $35.49M | – |
| Q2 FY2017 | Jul 1, 2017 | $36.57M | – |
| Q1 FY2017 | Apr 1, 2017 | $36.35M | – |
| Q4 FY2016 | Dec 31, 2016 | $35.39M | – |
See a number that looks wrong?